Abstract:Cellular senescence is an irreversible cell arrest process, which is determined by a variety of complicated mechanisms, including telomere attrition, mitochondrial dysfunction, metabolic disorders, loss of protein homeostasis, epigenetic changes, etc. Cellular senescence is causally related to the occurrence and development of age-related disease. The elderly is liable to suffer from disorders such as neurodegenerative diseases, cancer, and diabetes. Therefore, it is increasingly imperative to explore specific countermeasures for the treatment of age-related diseases. Numerous studies on humans and mice emphasize the significance of metabolic imbalance caused by short telomeres and mitochondrial damages in the onset of age-related diseases. Although the experimental data are relatively independent, more and more evidences have shown that there is mutual crosstalk between telomeres and mitochondrial metabolism in the process of cellular senescence. This review systematically discusses the relationship between telomere length, mitochondrial metabolic disorder, as well as their underlying mechanisms for cellular senescence and age-related diseases. Future studies on telomere and mitochondrial metabolism may shed light on potential therapeutic strategies for age-related diseases.Graphical The characteristics of cellular senescence mainly include mitochondrial dysfunction and telomere attrition. Mitochondrial dysfunction will cause mitochondrial metabolic disorders, including decreased ATP production, increased ROS production, as well as enhanced cellular apoptosis. While oxidative stress reaction to produce ROS, leads to DNA damage, and eventually influences telomere length. Under the stimulation of oxidative stress, telomerase catalytic subunit TERT mainly plays an inhibitory role on oxidative stress, reduces the production of ROS and protects telomere function. Concurrently, mitochondrial dysfunction and telomere attrition eventually induce a range of age-related diseases, such as T2DM, osteoporosis, AD, etc. :increase; :reduce;⟝:inhibition.

Targeting Mitochondrial Oxidative Stress as a Strategy to Treat Aging and Age-Related Diseases

Targeting Mitochondria as a Strategy to Inhibit Cellular Senescence

Targeting organ-specific mitochondrial dysfunction to improve biological aging

Enhancing healthy aging with small molecules: A mitochondrial perspective

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment

Targeting the Mitochondria-Proteostasis Axis to Delay Aging

The Potential of Mitochondrial Therapeutics in the Treatment of Oxidative Stress and Inflammation in Aging

Mitochondrial homeostasis: a potential target for delaying renal aging

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Mitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches

Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging 1

Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue

Mitochondria: A Potential Rejuvenation Tool against Aging

Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases

Mitochondrial and metabolic dysfunction in ageing and age-related diseases

Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress

Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies